Q4 2023: Eventful quarter caps transformative year
Important events during the fourth quarter · Net sales increased by 8% (9% adjusted for currency effects) to SEK 156 m (144). · The EBITDA margin amounted to 12% (11) or 15% adjusted for items affecting comparability. · Probi launchd Probi[®] Sensia, a brand new product concept in mental health. · Probi launched two new scientifically proven synbiotic solutions together with Clasado Biosciences at Supply Side West in Las Vegas. · Per Lindblad took over as CFO on November 1st. · The Board of Directors proposed a dividend for the fiscal year 2023 of a total of SEK 14,8m,